Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Gains from Investment Securities (2018 - 2025)

Historic Gains from Investment Securities for Organogenesis Holdings (ORGO) over the last 8 years, with Q3 2025 value amounting to $11.9 million.

  • Organogenesis Holdings' Gains from Investment Securities rose 35034.05% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.9 million, marking a year-over-year increase of 35034.05%. This contributed to the annual value of $10.6 million for FY2024, which is 1310.31% up from last year.
  • Organogenesis Holdings' Gains from Investment Securities amounted to $11.9 million in Q3 2025, which was up 35034.05% from $12.0 million recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' Gains from Investment Securities peaked at $23.2 million during Q4 2021, and registered a low of -$70000.0 during Q4 2022.
  • For the 5-year period, Organogenesis Holdings' Gains from Investment Securities averaged around $3.9 million, with its median value being $1.6 million (2023).
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first soared by 345668.2% in 2021, then plummeted by 10030.23% in 2022.
  • Organogenesis Holdings' Gains from Investment Securities (Quarter) stood at $23.2 million in 2021, then plummeted by 100.3% to -$70000.0 in 2022, then skyrocketed by 1144.29% to $731000.0 in 2023, then soared by 434.61% to $3.9 million in 2024, then soared by 204.29% to $11.9 million in 2025.
  • Its Gains from Investment Securities was $11.9 million in Q3 2025, compared to $12.0 million in Q2 2025 and $1.8 million in Q1 2025.